​

Fennec Pharmaceuticals (FENC) Stock Forecast, Price Target & Predictions

OverviewRevenueOwnershipFinancialsChartTranscripts

FENC Stock Forecast

Fennec Pharmaceuticals (FENC) stock forecast, based on 12 Wall Street analysts, predicts a 12-month average price target of $15.75, with a high of $19.00 and a low of $12.00. This represents a 143.43% increase from the last price of $6.47.

- $4 $8 $12 $16 $20 High: $19 Avg: $15.75 Low: $12 Last Closed Price: $6.47

FENC Stock Rating

Fennec Pharmaceuticals stock's rating consensus is Buy, based on 12 Wall Street analysts. The breakdown includes 0 Strong Buy (0.00%), 11 Buy (91.67%), 1 Hold (8.33%), 0 Sell (0.00%), and 0 Strong Sell (0.00%).

Buy
Total 12 0 1 11 Strong Sell Sell Hold Buy Strong Buy

FENC Forecast vs Benchmarks

TypeNameUpside
StockFennec Pharmaceuticals143.43%
SectorHealthcare Stocks 25.20%
IndustryBiotech Stocks 63.35%

Price Target Trends

1M3M12M
# Anlaysts--4
Avg Price Target--$17.00
Last Closing Price$6.47$6.47$6.47
Upside/Downside--162.75%
Ratings Trends
DateStrong BuyBuyHoldSellStrong SellTotal
Jan, 2523---5
Dec, 2423---5
Nov, 2423---5
Oct, 2425---7
Sep, 2425---7
Latest Price Target by Analysts
DateAnalystCompanyPrice TargetPrice when PublishedPrice Target/Price when PublishedPrice Target/Last Closing Price
May 15, 2024Chase KnickerbockerCraig-Hallum$17.00$7.34131.61%162.75%
May 15, 2024Raghuram SelvarajuH.C. Wainwright$15.00$7.03113.37%131.84%
Apr 04, 2024Raghuram SelvarajuH.C. Wainwright$18.00$10.7767.13%178.21%
Mar 19, 2024Chase KnickerbockerCraig-Hallum$18.00$11.0163.49%178.21%
Nov 22, 2022Cantor Fitzgerald$12.00$9.1730.86%85.47%
Sep 26, 2022Wedbush$19.00$7.11167.23%193.66%
Latest Upgrade/Downgrade by Analysts
DateCompanyPrevious RatingNew RatingRating Change
May 15, 2024Craig-HallumBuyBuyhold
May 15, 2024H.C. WainwrightBuyBuyhold
Apr 04, 2024H.C. WainwrightBuyBuyhold
Nov 22, 2022Cantor FitzgeraldOverweightupgrade
Sep 26, 2022WedbushOutperformOutperformhold
Sep 07, 2022JonesTradingBuyinitialise

Financial Forecast

EPS Forecast

$-2 $-1 $0 $1 $2 $3 Dec 21 Dec 22 Dec 23 Dec 24 Dec 25 Dec 26 Dec 27 Dec 28
Dec 21Dec 22Dec 23Dec 24Dec 25Dec 26Dec 27Dec 28
Reported$-0.67$-0.95$-0.61-----
Avg Forecast$0.25$-0.92$-0.51$-0.07$-0.03$1.07$1.66$2.09
High Forecast$0.20$-1.22$-0.53$-0.10$-0.09$0.36$0.55$1.54
Low Forecast$0.30$-0.75$-0.49$-0.04$0.07$2.11$2.83$2.74
Surprise %-368.00%3.26%19.61%-----

Revenue Forecast

$0 $30M $60M $90M $120M $150M Dec 21 Dec 22 Dec 23 Dec 24 Dec 25 Dec 26 Dec 27 Dec 28
Dec 21Dec 22Dec 23Dec 24Dec 25Dec 26Dec 27Dec 28
Reported-$1.53M$21.64M-----
Avg Forecast$50.00M$893.80K$20.19M$43.03M$48.18M$82.47M$102.98M$115.61M
High Forecast$42.61M$768.36K$16.12M$29.93M$40.83M$81.12M$100.66M$92.32M
Low Forecast$57.19M$1.12M$25.07M$56.13M$55.53M$83.83M$105.31M$143.54M
Surprise %-71.74%7.18%-----

Net Income Forecast

$-100M $-60M $-20M $20M $60M $100M Dec 21 Dec 22 Dec 23 Dec 24 Dec 25 Dec 26 Dec 27 Dec 28
Dec 21Dec 22Dec 23Dec 24Dec 25Dec 26Dec 27Dec 28
Reported$-17.46M$-24.84M$-16.34M-----
Avg Forecast$-47.38M$-24.36M$-13.55M$-1.13M$-1.15M$29.83M$46.35M$55.41M
High Forecast$-56.85M$-32.40M$-14.11M$-2.78M$-2.33M$9.57M$14.62M$40.89M
Low Forecast$-37.90M$-19.92M$-13.00M$-1.07M$1.85M$56.07M$75.20M$72.80M
Surprise %-63.15%1.97%20.56%-----

FENC Forecast FAQ

Is Fennec Pharmaceuticals stock a buy?

Fennec Pharmaceuticals stock has a consensus rating of Buy, based on 12 Wall Street analysts. The rating breakdown includes 0 Strong Buy, 11 Buy, 1 Hold, 0 Sell, and 0 Strong Sell, reflecting a consensus that Fennec Pharmaceuticals is a favorable investment for most analysts.

What is Fennec Pharmaceuticals's price target?

Fennec Pharmaceuticals's price target, set by 12 Wall Street analysts, averages $15.75 over the next 12 months. The price target range spans from $12 at the low end to $19 at the high end, suggesting a potential 143.43% change from the previous close price of $6.47.

How does Fennec Pharmaceuticals stock forecast compare to the average forecast of its sector, industry, and investment themes?

Fennec Pharmaceuticals stock forecast shows a 143.43% upside, outperforming the average forecast for the healthcare stocks sector (25.20%) and outperforming the biotech stocks industry (63.35%).

What is the breakdown of analyst ratings for Fennec Pharmaceuticals over the past three months?

  • January 2025: 40.00% Strong Buy, 60.00% Buy, 0% Hold, 0% Sell, 0% Strong Sell.
  • December 2024: 40.00% Strong Buy, 60.00% Buy, 0% Hold, 0% Sell, 0% Strong Sell.
  • November 2024: 40.00% Strong Buy, 60.00% Buy, 0% Hold, 0% Sell, 0% Strong Sell.

What is Fennec Pharmaceuticals’s EPS forecast?

Fennec Pharmaceuticals's average annual EPS forecast for its fiscal year ending in December is -0.07 for 2024, a -88.52% decrease from the reported $-0.61 in 2023. The prediction for 2025 is $-0.03, $1.07 for 2026, $1.66 for 2027, and $2.09 for 2028.

What is Fennec Pharmaceuticals’s revenue forecast?

Fennec Pharmaceuticals's average annual revenue forecast for its fiscal year ending in December is $43.03M for 2024, a 98.82% increase from the reported $21.64M in 2023. The forecast for 2025 is $48.18M, $82.47M for 2026, $102.98M for 2027, and $115.61M for 2028.

What is Fennec Pharmaceuticals’s net income forecast?

For its fiscal year ending in December, Fennec Pharmaceuticals's average annual net income forecast is $-1.133M for 2024, reflecting a -93.07% decrease from the reported $-16.339M in 2023. The projection for 2025 is $-1.147M, $29.83M for 2026, $46.35M for 2027, and $55.41M for 2028.